Keyphrases
Bladder Cancer
72%
Radical Cystectomy
52%
Ileal Conduit
43%
Confidence Interval
42%
Narrow Band Imaging
39%
Muscle-invasive Bladder Cancer
39%
Photodynamic Diagnosis
39%
Flexible Cystoscopy
39%
Neoadjuvant Chemotherapy
39%
Robot-assisted Laparoscopy
39%
Robot-assisted Radical Cystectomy
39%
Diagnostic Value
39%
White Light
37%
Randomized Controlled Trial
34%
Cystectomy
33%
Single Center
32%
Non-muscle Invasive Bladder Cancer (NMIBC)
30%
Transurethral Resection of Bladder Tumor (TURBT)
28%
Carcinoma in Situ
27%
Denmark
26%
Ureteral Stricture
21%
CpG Island
19%
Why-not
19%
Custom Design
19%
Flat Dysplasia
19%
Urine Specimen
19%
Cancer Application
19%
Clinical Significance
19%
Tumor Specimens
19%
Synthetic Probes
19%
Laparoscopic Stapler
19%
High-grade Urothelial Carcinoma
19%
Maneuverability
19%
Ileoileal
19%
Epigenetic Analysis
19%
Nationwide Observational Study
19%
Hypermethylation
19%
Methylation Analysis
19%
Transabdominal
19%
Squamous Cell Carcinoma (SqCC)
19%
Multiplex Ligation-dependent Probe Amplification
19%
Genetic Analysis
19%
Trial Feasibility
19%
Anastomosis
19%
High-risk Human Papillomavirus (HR-HPV)
19%
Porcine Study
19%
Postoperative Complications
19%
Total Intravenous Anesthesia
19%
FGFR3 mutation
19%
Intracorporeal Urinary Diversion
19%
Medicine and Dentistry
Cystectomy
100%
Stricture
48%
Bladder
46%
Cystoscopy
46%
Ileal Conduit
45%
Transitional Cell Carcinoma
43%
Narrow Band Imaging
39%
Randomized Controlled Trial
38%
Bladder Cancer
29%
Diagnosis
28%
Bladder Tumor
27%
Transurethral Resection
27%
Carcinoma in Situ
27%
Urinary Diversion
24%
Surgical Anastomosis
20%
Overall Survival
20%
Dysplasia
19%
Confocal Laser Scanning Microscopy
19%
Observational Study
19%
Muscle Invasive Bladder Cancer
19%
Recurrent Disease
19%
Endoscopic Biopsy
19%
Neoadjuvant Chemotherapy
19%
Postoperative Complication
19%
Total Intravenous Anesthesia
19%
Squamous Cell Carcinoma
19%
Wart Virus
19%
Laparoscopic Surgery
19%
Urology
16%
Tumor Recurrence
15%
Non Muscle Invasive Bladder Cancer
14%
Da Vinci Surgical System
14%
Open Surgery
12%
Recurrence Free Survival
11%
Cancer Specific Survival
11%
Neoplasm
11%
Surgeon
11%
Propofol
9%
Sevoflurane
9%
Intraocular Pressure
9%
Prostatectomy
9%
Biopsy
8%
Ureter
8%
Odds Ratio
7%
Neobladder
7%
Nephroureterectomy
7%
Proportional Hazards Model
6%
Outpatient
6%
Cancer Surgery
5%
Disease Specific Survival
5%